Skip to content

Study on Pidari Vatham with Varma manipulation with Kazhuthu Varma Kudineer and Etti thylam

An open labelled double arm non randomised phase II clinical trial ,To compare the efficacy of Varma Manipulation with Kazhuthu Varma Kudineer (Internal) and Etti Thylam(External) in the treatment of Pidari Vatham

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019602
Enrollment
40
Registered
2019-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: VARMA MANIPULATION: VARMA MANIPULATION WITH KAZHUTHU VARMA KUDINEER (INTERNAL) 90 ml bd before food for 3 days AND ETTI THYLAM (EXTERNAL) 30 ml Control Intervention1: nil: nil

Sponsors

M RAJESWARI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pain in the nape of the neck With or without numbness and pain in the upperlimbs Neck stiffness Giddiness Patient who are willing for admission and stay in IPD or willing to attend OPD Patient willing to sign Informed consent document

Exclusion criteria

Exclusion criteria: History of Trauma of neck/ Neck surgery Neoplasm / Tuberculosis in spine Severe osteoporosis of Cervical spine Congenital anomalies of spine Ankylosing spondylosis Pregnant women and Lactating mothers Patients with any other serious systemic illness Spina bifida Cervical rib Syringomyelia Patient who are having the skin disease

Design outcomes

Primary

MeasureTime frame
Comparison of change from baseline in Oswestry Neck Disability Index at day fourtey eight between Group one and Group twoTimepoint: WITHIN 30 DAYS SYMPTOMS WILL BE REDUCED

Secondary

MeasureTime frame
The Copenhagen Neck functional disability scale Functional strength of the cervical spine Timepoint: Group I Intermittent varma manipulation within 48 days Ist sitting - 50 percentage of symptoms will reduce IInd sitting - 80 percentage of symptoms will reduce Group II - After giving internal and external medicine for 3 days 40 percentage of primary symptoms will reduce Afer 48 days completion 80 percentage of symptoms will reduce

Countries

India

Contacts

Public ContactS SUJATHA

GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL

rajasekarsujatha@gmail.com9442331462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026